News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Abbott Laboratories Calls Off Sale Of Flu Vaccine Business In Europe
September 3, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
New York Times -- Abbott Laboratories has called a halt to the sale of its European flu-vaccine unit because of a dissapointing run of initial bids, The Wall Street Journal reported.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Abbott Laboratories
MORE ON THIS TOPIC
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
·
1 min read
·
Dan Samorodnitsky
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
July 9, 2025
·
1 min read
·
Dan Samorodnitsky
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
July 9, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
·
1 min read
·
Annalee Armstrong
